Adler H, Gould S, Hine P, et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis 2022; published online May 24. https://doi.org/10.1016/S1473-3099(22)00228-6—In this Article the seventh sentence of the Findings in the Summary should read “One patient was treated with tecovirimat (600 mg twice daily for 2 weeks orally)”. This correction has been made to the online version as of May 26, 2022, and will be made to the printed version.
. 2022 May 26;22(7):e177. doi: 10.1016/S1473-3099(22)00353-X
Correction to Lancet Infect Dis 2022; published online May 24. https://doi.org/10.1016/S1473-3099(22)00228-6
Issue date 2022 Jul.
© 2022 Elsevier Ltd. All rights reserved.
Elsevier has created a Monkeypox Information Center (https://www.elsevier.com/connect/monkeypox-information-center) in response to the declared public health emergency of international concern, with free information in English on the monkeypox virus. The Monkeypox Information Center is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its monkeypox related research that is available on the Monkeypox Information Center - including this research content - immediately available in publicly funded repositories, with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the Monkeypox Information Center remains active.
PMCID: PMC9629673 PMID: 35644159
This corrects the article "Clinical features and management of human monkeypox: a retrospective observational study in the UK" on page 1153.